Amrutanjan Health Care Limited announced its audited financial results for the quarter and year ended March 31, 2026, during its board meeting held on May 8, 2026. The company reported a revenue from operations of ₹149.77 Crores for the current quarter, reflecting a 6.19% increase from the previous quarter’s ₹141.04 Crores and a 10.60% rise compared to the ₹135.41 Crores earned in the same quarter last year. Net profit for the quarter stood at ₹16.19 Crores, which is a 16.76% decrease from the ₹19.45 Crores reported in the previous quarter, but shows a 6.65% growth over the ₹15.18 Crores recorded in the corresponding quarter of the previous year. Additionally, the Board has recommended a final dividend of ₹2.90 per equity share for the financial year 2025-26.

Amrutanjan Health Care Limited is a century-old Indian company specializing in over-the-counter (OTC) health products, women’s hygiene, and beverages. Founded in 1893, it is widely recognized for its iconic pain management balm and has expanded its portfolio to include sanitary napkins and fruit-based drinks. The company operates primarily through its OTC, Women’s Hygiene & Personal Care, and Beverages segments, continuing to maintain a strong presence in the Indian consumer healthcare market.